Bay Pharma

Bay Pharma is an independent Australian pharmaceutical sponsor specialising in therapeutic vaping products for smoking cessation and the management of nicotine dependence.

Operating within Australia’s regulated therapeutic vaping framework, Bay Pharma develops and supplies products in accordance with applicable regulatory requirements. Its approach is firmly focused on therapeutic use, supported by responsible supply practices to minimise access by young people and non-smokers

Across product development, quality assurance, regulatory compliance and supply, Bay Pharma maintains a consistent focus on quality, consistency and responsible product stewardship.

Year founded: 2022
Headquarters located: Sydney, NSW

Innovation in smoking cessation products

Bay Pharma is focused on advancing therapeutic options for smoking cessation and the management of nicotine dependence, applying a clinical approach to product development, quality and responsible supply. A range of dosage options is available to support treatment planning by healthcare professionals.

It combines consistent quality and compliance standards across product development and device design, with particular attention to formulation consistency, aerosol performance and independent testing. Bay Pharma continue to invest in research, testing and collaboration with healthcare, scientific and manufacturing partners, as part of their product development.